Cita APA

Abrisqueta, P., Loscertales, J., Terol, M. J., Ramirez Payer, A., Ortiz, M., Perez, I., . . . Villanueva, M. (2021). Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).

Citación estilo Chicago

Abrisqueta, Pau, et al. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). 2021.

Cita MLA

Abrisqueta, Pau, et al. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). 2021.